A broad range of experimental and clinical evidence has highlighted the central role of
chronic inflammation in promoting tumor development. However, the molecular mechanisms …

T cells directed against mutant neo-epitopes drive cancer immunity. However, spontaneous
immune recognition of mutations is inefficient. We recently introduced the concept of …

Calprotectin (S100A8/A9), a heterodimer of the two calcium-binding proteins S100A8 and
S100A9, was originally discovered as immunogenic protein expressed and secreted by …

Purpose: Biomarkers for outcome after immune-checkpoint blockade are strongly needed
as these may influence individual treatment selection or sequence. We aimed to identify …

Purpose: Immunotherapy with ipilimumab improves the survival of patients with metastatic
melanoma. Because only around 20% of patients experience long-term benefit, reliable …

Background Recent studies have successfully demonstrated the use of deep-learning
algorithms for dermatologist-level classification of suspicious lesions by the use of excessive …

The immunosuppressive tumor microenvironment represents not only one of the key factors
stimulating tumor progression but also a strong obstacle for efficient tumor immunotherapy. …

Endothelial cells (ECs) provide angiocrine factors orchestrating tumor progression. Here,
we show that activated Notch1 receptors (N1ICD) are frequently observed in ECs of human …

Background Recent studies have demonstrated the use of convolutional neural networks (CNNs)
to classify images of melanoma with accuracies comparable to those achieved by …

Inhibitors of the receptor tyrosine kinase c-MET are currently used in the clinic to target
oncogenic signaling in tumor cells. We found that concomitant c-MET inhibition promoted …